
Haemonetics Announces Upsized Private Placement of $600 Million Convertible Senior Notes
Haemonetics Corporation (NYSE: HAE) has announced the pricing of its $600 million offering of 2.50% Convertible Senior Notes due 2029. This private offering, increased from an initial $525 million, targets…












